The integration of immunotherapy in the perioperative setting of muscle-invasive urothelial carcinoma (MIUC) appears promising. SAKK 06/17 investigated the addition of neoadjuvant durvalumab to ...

Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: another weapon in the armamentarium. J Thorac Dis 2025;17 (5):3472-3477. doi: 10.21037/jtd-2025-91 ...

ALNEO included patients with potentially resectable disease and treated them with neoadjuvant alectinib for two cycles, ...

Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Perioperative regimens may combine benefits of both to improve long ...

Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain ...

In this symposium, Frank Griesinger, Cecilia Pompili, and Jesme Fox discussed the latest evidence for neoadjuvant ...

CHICAGO — Adding perioperative durvalumab to standard combination chemotherapy significantly improved EFS for certain adults with locally advanced gastric or gastroesophageal junction cancers ...

The perioperative timeframe is pivotal in determining long-term cancer outcomes. This Review covers the various aspects of surgery which could facilitate the metastatic process. Through ...

Overall, 224 patients with resectable adenocarcinoma of the lower esophagus, gastroesophageal junction (GEJ), or stomach were randomly assigned to either perioperative chemotherapy and surgery (CS ...

Perioperative strokes result in a prolonged hospital stay and increased rates of disability, discharge to long-term care facilities, and death after surgery. 7 ...